The estimated Net Worth of Anthony R Tersigni is at least $386 Tausend dollars as of 21 May 2022. Anthony Tersigni owns over 5,151 units of R1 RCM stock worth over $356,389 and over the last 13 years he sold RCM stock worth over $0. In addition, he makes $30,000 as Director at R1 RCM.
Sign up
Anthony Tersigni RCM stock SEC Form 4 insiders trading
Anthony has made over 10 trades of the R1 RCM stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 5,151 units of RCM stock worth $72,732 on 21 May 2022.
The largest trade he's ever made was exercising 12,094 units of R1 RCM stock on 28 May 2021 worth over $170,767. On average, Anthony trades about 973 units every 102 days since 2012. As of 21 May 2022 he still owns at least 25,240 units of R1 RCM stock.
You can see the complete history of Anthony Tersigni stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Anthony Tersigni biography
Dr. Anthony R. Tersigni Ed.D is Director of the company. Dr. Tersigni is Chair of the Board of Ascension Capital, LLC, Ascension’s healthcare investment fund, and has served in this role since July 2019. Prior to this role, Dr. Tersigni served as President and Chief Executive Officer of Ascension from January 2012 until January 2019. Dr. Tersigni also served on the board of ProAssurance from May 2012 to May 2015. Before becoming the first President and Chief Executive Officer of Ascension in 2012, Dr. Tersigni had served as President and Chief Executive Officer of Ascension Health since 2004. Previously he served as Ascension Health’s Executive Vice President and Chief Operating Officer from 2001 through 2003. From 1995 to 2000, Dr. Tersigni was President and Chief Executive Officer at St. John Health, Detroit (now Ascension St. John), which at that time was Ascension Health’s largest integrated health system. He also served the St. John system as Executive Vice President and Chief Operating Officer from 1994 to 1995. The Company believes Dr. Tersigni’s proven leadership and extensive executive experience in healthcare, as well as his experience serving on hospital and corporate boards, qualify him to serve on the Boa
What is the salary of Anthony Tersigni?
As the Director of R1 RCM, the total compensation of Anthony Tersigni at R1 RCM is $30,000. There are 11 executives at R1 RCM getting paid more, with Joseph Flanagan having the highest compensation of $4,859,860.
How old is Anthony Tersigni?
Anthony Tersigni is 70, he's been the Director of R1 RCM since 2019. There are 3 older and 12 younger executives at R1 RCM. The oldest executive at R1 RCM Inc. is Michael Feiner, 77, who is the Independent Director.
What's Anthony Tersigni's mailing address?
Anthony's mailing address filed with the SEC is C/O R1 RCM INC., 433 W. ASCENSION WAY, SUITE 200, MURRAY, UT, 84123.
Insiders trading at R1 RCM
Over the last 8 years, insiders at R1 RCM have traded over $770,079,900 worth of R1 RCM stock and bought 103,238 units worth $1,376,421 . The most active insiders traders include Achi Series Lllptcp Asc Gp,..., Joseph Gerard Flanagan und John B Iii Henneman. On average, R1 RCM executives and independent directors trade stock every 27 days with the average trade being worth of $7,812,780. The most recent stock trade was executed by John M. Sparby on 6 March 2024, trading 10,046 units of RCM stock currently worth $143,959.
What does R1 RCM do?
R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.
What does R1 RCM's logo look like?
Complete history of Anthony Tersigni stock trades at R1 RCM und Proassurance
R1 RCM executives and stock owners
R1 RCM executives and other stock owners filed with the SEC include:
-
Joseph Flanagan,
President, Chief Executive Officer, Director -
Gary Long,
Executive Vice President, Chief Commercial Officer -
Joseph Gerard Flanagan,
Pres, CEO & Director -
Gary S. Long,
Exec. VP & Chief Commercial Officer -
Richard Evans,
Senior Vice President, Chief Accounting Officer, Corporate Controller -
Richard B. Evans Jr.,
Sr. VP, Corp. Controller & Chief Accounting Officer -
Rachel Wilson,
Exec. VP, CFO & Treasurer -
Alex Mandl,
Lead Independent Director -
Michael Feiner,
Independent Director -
Jill Smith,
Independent Director -
John Henneman,
Independent Director -
Anthony Tersigni,
Director -
Anthony Speranzo,
Independent Director -
Rachel Wilson,
Chief Financial Officer, Treasurer -
Atif Rahim,
Senior Vice President - Investor Relations & Business Development -
Vijay Kotte,
Executive Vice President - Physician Services -
Ian Sacks,
Independent Director -
Neal Moszkowski,
Independent Director -
Albert Zimmerli,
Director -
Vijay Kumar Kotte,
Exec. VP of Strategy & Corp. Devel. and Chief Solutions Officer -
Sean Radcliffe,
Exec. VP, Gen. Counsel & Corp. Sec. -
Corey Perman,
Exec. VP of Compliance & Risk -
Jay Sreedharan,
Chief Technology & Digital Officer -
John M. Sparby,
Exec. VP of Operations & Delivery and COO -
Charles J. Ditkoff,
Director -
Steven J Shulman,
Director -
Christopher Simon Ricaurte,
Chief Financial Officer -
Mountain Capital, L.L.C.Coy...,
-
Pamela L. Spikner,
Principal Accounting Officer -
Thomas A Lesica,
Chief Operating Officer -
Bradford Kyle Armbrester,
Director -
Jeremy Delinsky,
Director -
David M Dill,
Director -
Scanlan Agnes Bundy,
Director -
Lee Rivas,
Chief Executive Officer -
John M. Sparby,
President -
Jennifer D. Williams,
Chief Financial Officer -
Kyle Hicok,
Chief Commercial Officer